Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 26, 2021

SELL
$1.74 - $2.6 $22,794 - $34,060
-13,100 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$1.51 - $4.23 $19,781 - $55,413
13,100 New
13,100 $24,000

Others Institutions Holding CTXR

About Citius Pharmaceuticals, Inc.


  • Ticker CTXR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,130,000
  • Market Cap $376M
  • Description
  • Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...
More about CTXR
Track This Portfolio

Track Triton Wealth Management, Pllc Portfolio

Follow Triton Wealth Management, Pllc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triton Wealth Management, Pllc, based on Form 13F filings with the SEC.

News

Stay updated on Triton Wealth Management, Pllc with notifications on news.